Trademark: 79115050
Word
SEQUESSOME TECHNOLOGY
Status
Dead
Status Code
709
Status Date
Friday, May 17, 2024
Serial Number
79115050
Registration Number
4427020
Registration Date
Tuesday, November 5, 2013
Mark Type
4
Filing Date
Tuesday, December 20, 2011
Published for Opposition
Tuesday, August 20, 2013
Cancellation Date
Friday, May 17, 2024

Trademark Owner History
Pro Bono Bio Entrepreneur Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of pain and inflammation; [ veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation; pharmaceuticals for the treatment of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; anti-inflammatory drugs; ] medicated creams, medicated dispersions, medicated lotions, medicated ointments, medicated gels [, medicated solutions, medicated sprays, medicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain or inflammation; chemical preparations for pharmaceutical or medical purposes, namely, the treatment of pain and inflammation; pharmaceuticals in the fields of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal disease and central nervous system diseases, namely, vesicles which physically absorb and remove chemicals; pharmaceutical preparations, namely, topical and parenteral preparations in the form of vesicles; pharmaceutical preparations in the form of vesicles for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammation; dispersions for pharmaceuticals for the treatment of pain and inflammation; medicated cosmetic and veterinary preparations, namely, dispersions and dry preparations of liposomal active substance carriers for the treatment of pain and inflammation; cosmeceutical preparations in the nature of medicated cosmetics; pharmaceutical preparations, namely, lipids for topical and parenteral use for the treatment of pain and inflammation; surfactants for medical use dispersed in the form of liquids, creams, gels, lotions, or liquid treatment sprays and lotions, being pharmaceutical preparations for the treatment of or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque-type psoriasis, seborrhoeic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout, macular degeneration, fungal disease and disorders related to fatty acid deficiencies ]
10 [ Medical devices in the nature of a carrier with nanostructures which cross through the skin allowing subcutaneous absorption for the treatment of pain; ] molecular filtering devices for medical use, namely, a liquid, gel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical [ and veterinary ] devices, namely, a medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and which contribute to the lubricating properties of synovial fluid [ ; medical instruments and devices for the administration of skin disease therapy and pain therapy and prophylaxis preparations and substances ]
"TECHNOLOGY"

Trademark Events
Aug 3, 2012
New Application Office Supplied Data Entered
Aug 2, 2012
Sn Assigned For Sect 66a Appl From Ib
Feb 11, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 11, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 11, 2013
Teas Response To Office Action Received
Aug 3, 2012
Assigned To Examiner
Aug 7, 2012
Application Filing Receipt Mailed
Aug 9, 2012
Non-Final Action Written
Aug 10, 2012
Non-Final Action (Ib Refusal) Prepared For Review
Aug 10, 2012
Refusal Processed By Mpu
Aug 10, 2012
Non-Final Action Mailed - Refusal Sent To Ib
Sep 1, 2012
Refusal Processed By Ib
Jul 17, 2013
Approved For Pub - Principal Register
Feb 12, 2013
Assigned To Lie
Feb 14, 2013
Correspondence Received In Law Office
Feb 14, 2013
Teas/Email Correspondence Entered
Mar 8, 2013
Final Refusal Written
Mar 8, 2013
Final Refusal E-Mailed
Mar 8, 2013
Notification Of Final Refusal Emailed
Jul 15, 2013
Teas Request For Reconsideration Received
Jul 15, 2013
Correspondence Received In Law Office
Jul 15, 2013
Teas/Email Correspondence Entered
Jul 31, 2013
Notification Of Notice Of Publication E-Mailed
Feb 7, 2014
Final Disposition Notice Sent To Ib
Feb 28, 2014
Final Decision Transaction Processed By Ib
Jul 17, 2013
Assigned To Lie
Jul 17, 2013
Law Office Publication Review Completed
Aug 20, 2013
Published For Opposition
Aug 20, 2013
Official Gazette Publication Confirmation E-Mailed
Nov 5, 2013
Registered-Principal Register
Feb 5, 2014
Final Disposition Notice Created, To Be Sent To Ib
Feb 7, 2014
Final Disposition Processed
Nov 5, 2018
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 14, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 14, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 9, 2019
New Representative At Ib Received
Nov 5, 2019
Teas Section 71 & 15 Received
Dec 9, 2019
Case Assigned To Post Registration Paralegal
Jan 3, 2020
New Representative At Ib Received
Jan 7, 2020
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Jan 7, 2020
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Jan 7, 2022
International Registration Renewed
Nov 5, 2022
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
May 17, 2024
Cancelled Section 71

Trademark Alertz updated from USPTO on 2030-01-24